Podcasts about cancer care

Send us a textWhat's the plan for The Rub and Healwell in 2026?Support the showSubscribe to our Substack: "More Than Hands" Send us an email: podcast@healwell.orgLeave us a voice message: 703-468-1799 Check out our interview-style podcast: InterdisciplinaryYou can support Healwell and the cool things we make by donating here!Ways join in: Leave us a review on Apple Podcasts Check out Healwell's live and online classes Continue the conversation with a free 3-day trial of the Healwell Community Find a copy of Rebecca Sturgeon's book: "Oncology Massage: An Integrative Approach to Cancer Care" Thank you to ABMP and AMTA for sponsoring us!Healwell is a 501(c)(3) non-profit based out of the Washington DC area. Check us out at www.healwell.org

Send us a textRead The Price of Free hereWe've all felt the frustration. How can we make therapeutic massage accessible? On top of that, how can we do that while maintaining professional value and sustainability? Many well-intentioned practitioners turn to volunteerism as a solution, offering free services at community events, for hospital staff, at health fairs, and just about anywhere else we're invited.While this impulse comes from a genuine desire to help, massage therapy volunteerism may actually perpetuate the very systemic problems it seeks to address. Bonus: it artificially depresses the entire profession's worth. It's like a coordinated effort to undermine ourselves, except nobody planned it.The solution to massage therapy access issues doesn't lie in an increase in free services. It lies in reframing massage therapy as a public health necessity rather than a luxury service.Support the showSubscribe to our Substack: "More Than Hands" Send us an email: podcast@healwell.orgLeave us a voice message: 703-468-1799 Check out our interview-style podcast: InterdisciplinaryYou can support Healwell and the cool things we make by donating here!Ways join in: Leave us a review on Apple Podcasts Check out Healwell's live and online classes Continue the conversation with a free 3-day trial of the Healwell Community Find a copy of Rebecca Sturgeon's book: "Oncology Massage: An Integrative Approach to Cancer Care" Thank you to ABMP and AMTA for sponsoring us!Healwell is a 501(c)(3) non-profit based out of the Washington DC area. Check us out at www.healwell.org

Send us a textRead this article hereWelcome to Practice-Based Research Networks (PBRNs); a simple idea with big potential!The Massage Therapy Foundation is building MassageNet, the largest (and only) international PBRN dedicated specifically to therapeutic massage.And they're building it for you.Support the showSubscribe to our Substack: "More Than Hands" Send us an email: podcast@healwell.orgLeave us a voice message: 703-468-1799 Check out our interview-style podcast: InterdisciplinaryYou can support Healwell and the cool things we make by donating here!Ways join in: Leave us a review on Apple Podcasts Check out Healwell's live and online classes Continue the conversation with a free 3-day trial of the Healwell Community Find a copy of Rebecca Sturgeon's book: "Oncology Massage: An Integrative Approach to Cancer Care" Thank you to ABMP and AMTA for sponsoring us!Healwell is a 501(c)(3) non-profit based out of the Washington DC area. Check us out at www.healwell.org

Send us a textRead this article hereEmotional labor is work that involves managing your and other people's emotions. Emotion management (also known as emotion work) is how you actively shape and direct your feelings. Emotion management happens internally and is a private activity. It becomes emotional labor when that private activity becomes public work.This distinction matters. Support the showSubscribe to our Substack: "More Than Hands" Send us an email: podcast@healwell.orgLeave us a voice message: 703-468-1799 Check out our interview-style podcast: InterdisciplinaryYou can support Healwell and the cool things we make by donating here!Ways join in: Leave us a review on Apple Podcasts Check out Healwell's live and online classes Continue the conversation with a free 3-day trial of the Healwell Community Find a copy of Rebecca Sturgeon's book: "Oncology Massage: An Integrative Approach to Cancer Care" Thank you to ABMP and AMTA for sponsoring us!Healwell is a 501(c)(3) non-profit based out of the Washington DC area. Check us out at www.healwell.org

Send us a textRead this article here“Everyone who is engaging with humans—as a teacher, a psychotherapist, as a bodyworker—should be aware of the state of the other,” Porges explained. It's not dismissive to say this. It's foundational. Take a moment to consider how often you truly do this in your work. I'm not talking about structural or postural assessment, at least not in the way that many manual therapists typically do. I'm talking about sensing and feeling the level of autonomic reactivity your client [and you!] experience.When you become polyvagal-informed, you're evaluating your client's autonomic state through observation: their muscle tone, their breathing patterns, the quality of their voice, how they hold themselves in space. You're noticing who's tightly wrapped and who's more accessible, and these cues are often quite subtle. Support the showSubscribe to our Substack: "More Than Hands" Send us an email: podcast@healwell.orgLeave us a voice message: 703-468-1799 Check out our interview-style podcast: InterdisciplinaryYou can support Healwell and the cool things we make by donating here!Ways join in: Leave us a review on Apple Podcasts Check out Healwell's live and online classes Continue the conversation with a free 3-day trial of the Healwell Community Find a copy of Rebecca Sturgeon's book: "Oncology Massage: An Integrative Approach to Cancer Care" Thank you to ABMP and AMTA for sponsoring us!Healwell is a 501(c)(3) non-profit based out of the Washington DC area. Check us out at www.healwell.org

Send us a textRead this article hereThe massage therapy profession has problems. We have so many problems, those problems have bred and now have enough problematic offspring to hold a problematic family reunion.You're probably reading our Substack because you see these problems and you want to know how to fix them. You've probably thought of some plans yourself. How many times have we all had conversations that start with “Well, why don't we just [insert solution]? That would solve it!”The next time you start to have this conversation, stop right there and really look at that question.Why don't we just [insert solution]?The answer is that what you're asking for is really hard. If it was easy, it would have been accomplished already.Support the showSubscribe to our Substack: "More Than Hands" Send us an email: podcast@healwell.orgLeave us a voice message: 703-468-1799 Check out our interview-style podcast: InterdisciplinaryYou can support Healwell and the cool things we make by donating here!Ways join in: Leave us a review on Apple Podcasts Check out Healwell's live and online classes Continue the conversation with a free 3-day trial of the Healwell Community Find a copy of Rebecca Sturgeon's book: "Oncology Massage: An Integrative Approach to Cancer Care" Thank you to ABMP and AMTA for sponsoring us!Healwell is a 501(c)(3) non-profit based out of the Washington DC area. Check us out at www.healwell.org

Send us a textRead this article hereThe Work We Do But Won't NameScholars who study labor have a term for work that involves “particularized knowledge and sustained personal attention.” They call it intimate labor. According to scholar Viviana Zelizer's framework, this work includes things like shared secrets, bodily information, awareness of personal vulnerability, interpersonal rituals, and private languages.Read that list again. Now think about what happens in a massage therapy session.We know our clients' bodies in ways that even their partners may not. We hold their secrets about pain, about stress, about the divorce they haven't told anyone about yet. We know things about our clients we don't even realize we know, the way a janitor knows what a household discards, learning private details from what people throw away.Support the showSubscribe to our Substack: "More Than Hands" Send us an email: podcast@healwell.orgLeave us a voice message: 703-468-1799 Check out our interview-style podcast: InterdisciplinaryYou can support Healwell and the cool things we make by donating here!Ways join in: Leave us a review on Apple Podcasts Check out Healwell's live and online classes Continue the conversation with a free 3-day trial of the Healwell Community Find a copy of Rebecca Sturgeon's book: "Oncology Massage: An Integrative Approach to Cancer Care" Thank you to ABMP and AMTA for sponsoring us!Healwell is a 501(c)(3) non-profit based out of the Washington DC area. Check us out at www.healwell.org

Licensed clinical social worker Tammy Weitzman dedicated 23 years of her career to caring for cancer patients—from the moment of diagnosis through treatment, survivorship, and sometimes end of life. But her stellar track record as a source of comfort to ailing patients in their hour of need wasn't enough for her to keep her job. Tammy's story reveals how DEI ideology can infiltrate even the most sacred spaces in healthcare, ultimately costing her everything she'd worked for.Tammy describes how her workplace at Seattle's Fred Hutch Cancer Center transformed after 2017, when self-described "social justice warriors" entered her department. She was called a "white kike" by a colleague, harassed for her friendship with someone in the Trump administration, and subjected to mandatory DEI sessions that dismissed her own experiences with antisemitism. When she pushed back against an email encouraging therapists to bring political conversations into patient care, she received a three-page complaint accusing her of "white privilege"—and was terminated ten days later for "lack of ethnic sensitivity."We explore what it means when institutions prioritize ideology over their core mission, how the female-dominated helping professions have become breeding grounds for social aggression masked as compassion, and what it takes to rebuild after your career and character have been destroyed. Tammy shares how she filed a lawsuit that settled quickly, relocated across the country, and rebuilt her practice from the ground up—all while becoming a source of support for others experiencing similar persecution.A licensed clinical social worker for 25 years, Tammy Weitzman has presented her work around the world. Born and raised in Toronto, she completed her graduate degree in New York. Tammy spent most of her career caring for cancer patients and their families, particularly those undergoing treatment of hematologic malignancies such as leukemia, lymphoma, myeloma, and stem cell transplantation. Although gifted at her job, her career took a downturn when “woke” colleagues created a hostile working atmosphere, harassing her with antisemitic slurs. After she objected to a colleague sending a biased political article to social workers over company email, Tammy was abruptly terminated from her job in Seattle. Tammy now counsels in private practice as an LCSW in North Carolina.Tammy's counseling websiteEmail: tammyw@wefixbrains.comBooks mentioned in this episode:- Imagine Heaven by John Burke- Imagine the God of Heaven by John Burke[00:00:00] Start[00:07:22] Why Oncology: Father's Death from Cancer[00:11:57] Wisdom from a Dying Patient[00:20:41] 2017: Social Justice Warriors Arrive[00:34:28] Called a "White Kike" by Colleague[00:44:00] Friend in Trump Administration Exposed[00:54:19] Terminated for "Lack of Ethnic Sensitivity"[00:56:01] Decision to Fight Back[01:09:52] Filing Lawsuit and Rebuilding LifeROGD REPAIR Course + Community gives concerned parents instant access to over 120 lessons providing the psychological insights and communication tools you need to get through to your kid. Now featuring 24/7 personalized AI support implementing the tools with RepairBot! Use code SOMETHERAPIST2025 to take 50% off your first month.PODCOURSES: use code SOMETHERAPIST at LisaMustard.com/PodCoursesTALK TO ME: book a meeting.PRODUCTION: Looking for your own podcast producer? Visit PodsByNick.com and mention my podcast for 20% off your initial services.SUPPORT THE SHOW: subscribe, like, comment, & share or donate.Watch NO WAY BACK: The Reality of Gender-Affirming Care. Use code SOMETHERAPIST to take 20% off your order.MUSIC: Thanks to Joey Pecoraro for our song, “Half Awake,” used with gratitude & permission.ALL OTHER LINKS HERE. To support this show, please leave a rating & review on Apple, Spotify, or wherever you get your podcasts. Subscribe, like, comment & share via my YouTube channel. Or recommend this to a friend!Learn more about Do No Harm.Take $200 off your EightSleep Pod Pro Cover with code SOMETHERAPIST at EightSleep.com.Take 20% off all superfood beverages with code SOMETHERAPIST at Organifi.Check out my shop for book recommendations + wellness products.Show notes & transcript provided with the help of SwellAI.Special thanks to Joey Pecoraro for our theme song, “Half Awake,” used with gratitude and permission.Watch NO WAY BACK: The Reality of Gender-Affirming Care (our medical ethics documentary, formerly known as Affirmation Generation). Stream the film or purchase a DVD. Use code SOMETHERAPIST to take 20% off your order. Follow us on X @2022affirmation or Instagram at @affirmationgeneration.Have a question for me? Looking to go deeper and discuss these ideas with other listeners? Join my Locals community! Members get to ask questions I will respond to in exclusive, members-only livestreams, post questions for upcoming guests to answer, plus other perks TBD. ★ Support this podcast on Patreon ★

Guest: Gerard A. Silvestri MD, MS, Master FCCP Guest: Mariam Alexander, MD, PhD Guest: Jessica S. Donington, MD, MSCR The 2025 European Society for Medical Oncology Congress and World Conference on Lung Cancer revealed significant updates in non-small cell lung cancer care. Learn more as Drs. Gerard Silvestri, Mariam Alexander, and Jessica Donington review new data on EGFR- and ROS1-targeted therapies, perioperative immunotherapy, and multidisciplinary strategies to expand resectability in stage III non-small cell lung cancer. Dr. Silvestri is a pulmonologist and the Hillenbrand Professor of Thoracic Oncology at the Medical University of South Carolina. Dr. Alexander is an Assistant Professor of Medical Oncology at the Medical University of South Carolina. Dr. Donington is a Professor in Surgery and Chief of the Section of Thoracic Surgery at the University of Chicago. This program is produced in partnership with the American College of Chest Physicians and is sponsored by AstraZeneca.

Raymond Mailhot, MD, MPH, University of Miami, Miami, FL Recorded on December 2, 2025 Raymond Mailhot, MD, MPH Department of Radiation Oncology University of Miami Miami, FL Join us with Dr. Raymond Mailhot from the University of Miami as we explore how social determinants of health shape patient experiences, treatment decisions, and outcomes. He discusses the importance of cultural competence in delivering equitable, patient-centered care and shares practical communication strategies to better engage patients and collaborate effectively. This episode offers actionable insights to strengthen relationships and improve overall care quality. Tune in today to gain practical strategies that will enhance your approach to patient-centered care and drive better outcomes! Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Medical Debt Case Management Program for Patients Blood Cancer United Additional Resources for Patients

Send us a textMeghan Gutierrez is the Chief Executive Officer of the Lymphoma Research Foundation ( https://lymphoma.org/ ), the nation's largest nonprofit organization devoted to funding lymphoma research and education, advancing both the study of new cancer therapies and improved patient care.An expert in government relations and health care policy, Meghan has pursued an array of public policy issues during her career, ranging from mental health parity and rare disease awareness to medical technology and the treatment of chronic disease. Following her work as a Congressional staff member for Dr. Greg Ganske, one of the U.S. House of Representatives' foremost leaders on health care policy, she served as a health policy and communications advisor for several national nonprofit and educational institutions, including Columbia University and the Partnership for a Drug-Free America.Meghan joined the Lymphoma Research Foundation in 2008 as its chief program, policy and communications officer. She was a driving force behind programs such as the country's only Adolescent and Young Adult Lymphoma Initiative and development of the first mobile app for people with lymphoma. She became Chief Executive Officer in 2014. In this role Meghan represents the Foundation before several audiences, including the U.S. Congress, Department of Defense, Food and Drug Administration and National Institutes of Health. She has written and lectured extensively about the needs of lymphoma patients and served on committees and panels of the American Society of Clinical Oncology, American Society of Hematology, Institute of Medicine, and National Cancer Institute, among others.Jennifer Branstetter is Executive Director, North America Corporate Affairs & Patient Advocacy Lead at BeOne Medicines USA ( https://beonemedicines.com/ ), a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations.Jennifer has a demonstrated 25+ year history of working with Fortune 500 pharmaceutical companies, in government, and with nonprofits and the media, and has been a strategist for multi-faceted state and federal public affairs and patient advocacy campaigns.Previously, Jennifer was a Senior Director, Corporate Affairs (North America) at BeOne and also held positions at Cullari Communications Global, Branstetter Consulting, as Director of Policy and Planning in the Commonwealth of PA, Governor's Office, for Governor Tom Corbett, as Director of Education and Outreach for Pennsylvania Office of Attorney General, as Communications Manager for the Pennsylvania Bar Association, and as Deputy Press Secretary in the Pennsylvania Office of the Lieutenant Governor during the administration of Governor Tom Ridge.#MeghanGutierrez #JenniferBranstetter #BeOneMedicines #LymphomaResearchFoundation #PatientAdvocacy #PatientCentricAI #PatientNavigation #ClinicalTrialEligibility #FinancialToxicityDetection #PatientDistress #AutomatedInsuranceNavigation #EquityRadar #RegulatoryAdvocacy  #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

WBBM Noon Business Hour host Rob Hart sits down with Dr. Kevin King of City of Hope & Dr. Jose Sanchez of Humboldt Park Health to discuss the latest advancements in cancer care, their effort to provide these services to those who need it & much more!

Episode summaryAt 32, Marcia found a lump she assumed was “nothing.” It wasn't. In quick succession came diagnosis (May 1998), surgery including mastectomy and reconstruction, and years of hormone therapy. The shock gave way to a long, messy recovery marked by anxiety, tears, and the fierce desire to “be there” for her two young sons. Yoga entered as a lifeline: first disciplined Iyengar classes that rebuilt physical strength and steadiness, then Aṣṭāṅga for rhythm, breath, dṛṣṭi, and mental focus, and eventually yoga therapy informed by the pañcamaya kośa model—meeting herself where she was, day by day.Part two of Marcia's story is even more tender: years later, her 15-year-old son, Alex, was diagnosed with high-grade osteosarcoma. Eight months of aggressive chemotherapy, limb-saving surgery, infection, and eventual amputation followed. Through sleepless hospital nights and fragile windows at home, Marcia leaned on simple, steady practices—breath, gentle movement, and the sacred ordinary of hanging laundry in the sun. Key themesThe long arc of recovery: Treatment can be quick; integration takes time. Yoga created structure (set sequences, five-breath holds) that translated into emotional steadiness.From outer strength to inner ease: As physical stability returned, so did mental clarity and emotional regulation—sthira-sukham āsanam (PYS 2.46) in action.Rituals of the ordinary: In crisis, simple routines (breathing, gentle stretches, even doing the wash) become anchors of meaning and regulation.Pañcamaya kośa self-check: How am I—body, breath/energy, mind, personality/values, and meaning? Let practice be responsive, not rigid.Caregivers need care: Five minutes of breath can change the nervous system—and the day.Post-traumatic growth: Agency (“this diagnosis won't define our life”) and community support foster resilience.Yoga therapy in oncology: Practical tools for survivors and families; thoughtful scope of practice and team-based care.Memorable moments“I was angry at the interruption to my life—I didn't want cancer to stop me from living my dharma.”“The set sequence and five breaths made Aṣṭāṅga meditative; my body knew what came next, and my mind could rest.”“Hospital life means not moving, not sleeping, not eating well. At home, a decent meal, a real bed, and a few breaths on the mat felt holy.”“Supporting my son after amputation, I realized the PT's ‘Superman' was Śalabhāsana—the same human body, different language.”Practical takeaways (for listeners)Structure regulates: A consistent class or home sequence can downshift anxiety; predictability is medicine.Five-breath rule: Linger in postures long enough to feel the pose regulate the breath (and vice versa).Honor seasons: Your practice can be Iyengar-precise one season, Aṣṭāṅga-rhythmic the next, and kośa-guided thereafter. That's yoga.Caregiver micro-practices work: Three minutes of diaphragmatic breathing between scans or consults matters.Who this episode supportsPeople navigating or recovering from cancerParents and caregivers living in medical systemsYoga teachers/therapists seeking oncology-informed, nervous-system-first approachesAnyone rebuilding identity and routine after a health crisisAbout Marcia MercierWebsite: www.marcie.yoga.com Location: North London (UK)Offerings:Weekly online Yoga for Breast Cancer (Wednesdays 09:30–10:30 UK)1:1 Yoga Therapy (online & in person)Haṭha and Vinyāsa classes (online and local studios)Contributor with Get Me Back—a cancer-recovery community offering strength training, yoga, Pilates, and on-demand classes (getmeback.uk)Resources mentionedmarcie.yoga — contact and class scheduleGet Me Back (UK): membership and on-demand support for people post-treatmentHost reflectionMarcia's story is a fierce testament to the human spirit yoked to practice. In yogic terms, she modeled tapas without self-punishment, svādhyāya without self-absorption, and praṇidhāna without passivity. This is what it looks like when philosophy leaves the page and enters a hospital ward, a nursery, a kitchen, and a yoga mat. Healing is not linear; it is rhythmic—breath by breath, five breaths at a time.Connect with The Yoga Therapy HourWebsite: TheOptimalState.comInstagram & LinkedIn: Optimal State Yoga TherapySubscribe, rate, and share if this helped you or someone you love.Content note & disclaimerThis episode includes personal experiences with cancer and hospitalization. Yoga therapy is complementary and not a substitute for medical care. Please consult your healthcare team before beginning or modifying any practice.

The future of cancer care is shifting toward earlier detection, continuous monitoring, and truly personalized treatment powered by high-quality genomic insights. In this episode, Ajay Gannerkote, President of Integrated DNA Technologies, explains how rapid advances in genomics are transforming cancer diagnosis, precision medicine, and personalized care. He describes how IDT evaluates emerging technologies by combining custom manufacturing, high-quality reagents, and deep scientific partnerships to deliver clinically meaningful insights. Ajay highlights how NGS, MRD, and multi-cancer detection are expected to accelerate over the next 3–5 years, enabling far earlier diagnosis and more precise monitoring. He also underscores the power of collaboration, shares a rare pediatric success story, and reflects on leadership principles centered on trust, innovation, and an “obligation to dissent.” Tune in and learn how the next wave of genomic innovation is bringing precision medicine within reach for patients everywhere! Resources Connect with and follow Ajay Gannerkote on LinkedIn. Follow Integrated DNA Technologies on LinkedIn and visit their website!

We are joined by two leaders from Aminex Therapeutics, Mark Burns, President & CSO, and Jeff Judson, VP of Strategic Planning & Investor Relations, to discuss the groundbreaking development of Aminex 1501, a novel cancer therapy that is transforming oncology. This conversation dives into the science behind this innovative therapy, its distinctive funding journey, the promising clinical trial results, and the collaboration with CTI. Listen now to explore the significance of FDA orphan drug designation and what it means for advancing innovative treatments for rare cancers. 00:10 Aminex 1501 is introduced, along with its mission to fight cancer by removing essential growth factors from tumors, stimulating the immune system 00:43 The drug's effectiveness across a wide range of solid tumors, showcasing its tumor-agnostic approach 01:11 Mark shares the origin of Aminex, highlighting its unique funding by angel investors outside biotech and the absence of venture capital 02:01 Why they chose CTI as a partner: technical competence, responsiveness, and Midwest values 03:18 How the therapy removes polyamines from tumors, leading to profound immune responses in animal models 04:11 The team discusses receiving FDA orphan drug designation for neuroblastoma and ongoing pediatric trials at Penn State University 05:15 Insights into the treatment of six rare childhood cancers, with a focus on improving quality of life and minimizing side effects 05:56 Breast cancer and melanoma identified as promising indications for future focus, with neuroblastoma and others also in scope 06:23 Recap of clinical trial progress and milestones  07:19 Recognition of patients as heroes in advancing cancer therapeutics 08:03 How the therapy trains the immune system to recognize and attack cancer 08:57 The inspiration behind targeting polyamines and the development of DFMO and Aminex 1501 10:00 Anecdotes about early animal studies, dramatic tumor shrinkage, and the motivation to continue research 12:13 The team's passion for improving patient outcomes and the importance of collaboration 13:00 Information for patients interested in joining trials, with details on upcoming clinics and how to find more information on clinicaltrials.gov 

In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with two thoracic oncologists practicing in New Zealand—Dr. Laird Cameron from Auckland Hospital and Dr. Annie Wong from the University of Otago—about the unique challenges and approaches to lung cancer care in their island nation of 5.4 million people. The conversation explores New Zealand's healthcare coverage system, patient population characteristics including smoking rates, the current state of lung cancer screening programs, and how molecular testing is conducted for non-small cell lung cancer patients. Drs. Cameron and Wong discuss access to targeted therapies and immunotherapy, the drug approval process in New Zealand, cultural considerations and health disparities affecting lung cancer treatment, and the clinical research infrastructure available in the country. This global perspective highlights how IASLC members face different regional challenges while working toward common goals in advancing lung cancer care.

Beat Cancer host Chris Joyce speaks with Reese Olander, Managing Executive Director of Development for the UC Davis Comprehensive Cancer Center, about common misconceptions surrounding philanthropic giving, the various avenues available for giving, and, most importantly, how philanthropy can extend and enhance cancer care and treatment for our patients. You can learn more about available opportunities here. To learn more about the UC Davis Comprehensive Cancer Center, visit https://health.ucdavis.edu/cancer/

Oncologist and health care executive Yousuf Zafar discusses his article, "When cancer costs too much: Why financial toxicity deserves a place in clinical conversations." Yousuf explains the concept of "financial toxicity," a severe burden caused by both direct medical bills and indirect costs (like time off work or child care) associated with cancer treatment. He reveals the sobering statistic that over forty percent of patients deplete their savings within two years, but emphasizes that this distress is more than just a financial problem: it directly compromises treatment adherence, forcing some to skip appointments or forgo prescriptions. Yousuf highlights the critical lack of cost transparency in oncology and makes the case for why clinicians must proactively screen for financial strain just as they would for physical side effects. Discover why these difficult conversations about the cost of cancer are essential for improving patient outcomes and quality of life. Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's part of Microsoft Cloud for Healthcare, built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Please visit answersincme.com/860/IME-69386-replay1 to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, experts in NSCLC discuss how to harness targeted ADCs with practical, case-based insights to personalize care and improve outcomes in advanced lung cancer. Upon completion of this activity, participants should be better able to: Interpret the latest clinical trial data for approved and emerging antibody-drug conjugates (ADCs) in NSCLC; Recognize biomarker-driven strategies to guide treatment management in patients with NSCLC; and Apply evidence-based strategies for the individualized management of patients with NSCLC receiving ADC therapy.

About Ajay Gannerkote:Ajay Gannerkote is a global healthcare leader with deep experience spanning life sciences, medical devices, and healthcare services. Now serving as president of Integrated DNA Technologies (IDT), a Danaher company, he oversees the organization's growth and strategic direction from Redwood City, California. Before IDT, he led Siemens Healthineers' global ultrasound business as president and head, steering a complex, vertically integrated operation across more than 30 countries. Under his leadership, the business moved from negative growth and margins to strong, sustainable performance, becoming an industry leader in AI-driven clinical technology. Prior to that, he served as Director at KKR Capstone, where he co-led healthcare operations, drove large-scale transformations for portfolio companies, and created significant enterprise value across services and medical device sectors. Ajay spent more than a decade at McKinsey & Company as a partner in the Global Medical Products practice, advising Fortune 500 companies on product development, commercialization, operations, growth strategy, and large-scale turnarounds. Earlier in his career, he held leadership roles at Federal-Mogul, Cambridge Technology Partners, and Infosys, building a foundation in operations, technology, and global business integration. He holds an MBA in Corporate Strategy and Marketing from the University of Michigan's Ross School of Business and a bachelor's degree in Electronics and Telecommunications Engineering from the University of Mysore.Things You'll Learn:Genomic technologies, such as NGS and MRD, are enabling earlier cancer detection, sometimes years ahead of traditional diagnostic methods. This early visibility allows clinicians to intervene sooner and build more personalized treatment strategies.Precision medicine is rapidly maturing as high-quality genomic data becomes central to diagnosis, monitoring, and therapy planning. The next era of oncology will rely heavily on personalized, data-driven decisions.Collaboration across industry, researchers, and regulatory bodies is essential for breakthrough medical innovations. A recent case of a rare disease demonstrates how a coordinated effort can compress the journey from diagnosis to therapy into just a few months.Custom manufacturing and high-quality reagents are critical enablers of clinically reliable genomic insights. Tailored solutions allow researchers and clinicians to analyze tumor-specific markers with greater accuracy and confidence.Strong leadership in genomics requires trust, transparency, and a willingness to challenge assumptions. Ajay's “obligation to dissent” principle encourages continuous innovation and pushes teams to think beyond the status quo.Resources:Connect with and follow Ajay Gannerkote on LinkedIn.Follow Integrated DNA Technologies on LinkedIn and visit their website.

Healthcare innovation in cancer care often means new drugs or breakthrough therapies. But as Othman Laraki, co-founder and CEO of Color Health, explains, the most powerful impact comes from making proven tools work for everyone. In this episode, Othman shares his journey from Google and Twitter into healthcare, driven by his family's history with breast cancer. He describes how Color Health evolved from genetic testing into a full “virtual cancer clinic” that addresses screening, early detection, treatment navigation, and survivorship. We discuss the challenges of healthcare's multi-payer system, why distribution costs outweigh lab costs, and how focusing on efficiency and simplicity leads to better outcomes. Othman also reflects on the future of AI in medicine, from reducing friction in basic care to scaling clinical judgment across populations.     Music Credit: "Upbeat Corporate" by Music For Creators is licensed under CC BY (Creative Commons Attribution) via freemusicarchive.org.

Jim Foote, Co-Founder and CEO of First Ascent Biomedical, is changing the standard of care for cancer treatment from 'try and hope' to 'test and treat'. The First Ascent platform combines functional drug testing of fresh biopsies, genomic sequencing, and an AI engine to assess a large panel of drugs and identify the most likely to be effective. Clinical data show a high correlation between how cancer cells respond in the lab test and how patients respond to the same drug, and is seen as a treatment guide for refractory cancer patients to identify novel drug combinations. Jim explains, "Fundamentally speaking, if we look at everybody on this planet from a DNA and RNA perspective, there are 8 billion people, and each one of us is different from the others due to our DNA and RNA. So if we acknowledge that biologically we're all different, then the problem that we're trying to solve is if we're all different, why are we treating each patient with the same standard of care? A process that has existed for a hundred years, and again, they've made substantial advancements, but functional precision medicine is really an opportunity to move away from a standard that's based on the laws of averages and really treat people based on an individual level, developed by results that come from their individual biology."  "In oncology, these practices and standards have been developed over decades. And in some situations, some of these cancer protocols haven't been updated in decades. There had been continual advancements in things like immunotherapy. What I'll say is that in oncology, they're always looking for the silver bullet. It's in the genome, it's in a biomarker, it's in immuno-oncology, it's in an organoid, it's in all of those types of things. So they have always tried to find that silver bullet. Fundamentally, what we do in First Ascent is that we believe that we have enough bullets, per se. We have enough drugs, per se. We're just not using them in the right ways. " #FirstAscentBiomedical #Cancer #Oncology firstascentbiomedical.com Download the transcript here

Jim Foote, Co-Founder and CEO of First Ascent Biomedical, is changing the standard of care for cancer treatment from 'try and hope' to 'test and treat'. The First Ascent platform combines functional drug testing of fresh biopsies, genomic sequencing, and an AI engine to assess a large panel of drugs and identify the most likely to be effective. Clinical data show a high correlation between how cancer cells respond in the lab test and how patients respond to the same drug, and is seen as a treatment guide for refractory cancer patients to identify novel drug combinations. Jim explains, "Fundamentally speaking, if we look at everybody on this planet from a DNA and RNA perspective, there are 8 billion people, and each one of us is different from the others due to our DNA and RNA. So if we acknowledge that biologically we're all different, then the problem that we're trying to solve is if we're all different, why are we treating each patient with the same standard of care? A process that has existed for a hundred years, and again, they've made substantial advancements, but functional precision medicine is really an opportunity to move away from a standard that's based on the laws of averages and really treat people based on an individual level, developed by results that come from their individual biology."  "In oncology, these practices and standards have been developed over decades. And in some situations, some of these cancer protocols haven't been updated in decades. There had been continual advancements in things like immunotherapy. What I'll say is that in oncology, they're always looking for the silver bullet. It's in the genome, it's in a biomarker, it's in immuno-oncology, it's in an organoid, it's in all of those types of things. So they have always tried to find that silver bullet. Fundamentally, what we do in First Ascent is that we believe that we have enough bullets, per se. We have enough drugs, per se. We're just not using them in the right ways. " #FirstAscentBiomedical #Cancer #Oncology firstascentbiomedical.com Listen to the podcast here

Welcome back to the Pear Healthcare Playbook! Today we're thrilled to sit down with Othman Laraki, Co-founder and CEO of Color Health, a company reinventing cancer care through a virtual-first, end-to-end model. Othman has spent his career at the intersection of technology and healthcare—from helping build Chrome at Google to leading product at Twitter to founding Color, where he now focuses on expanding access to high-quality cancer prevention, screening, and treatment.In this episode, we explore how Color got started, what the team learned transitioning from genomics into full-stack care delivery, and why reducing friction across the care pathway is critical for improving outcomes. We dive into how Color's model works across the entire cancer journey, how the company thinks about system-level change and distribution, and how AI—through collaborations with OpenAI and Google Cloud—is powering new capabilities for patients and clinicians.

GCI Health, Fersen and Fierce Pharma, hosts Ryan Kurzman and Wendy Lund explore the fast-shifting landscape of cancer care with Pam Traxel of the American Cancer Society Cancer Action Network. Traxel outlines the growing complexity facing patients—from navigating an expanding range of treatment options to managing rising costs—and explains why access to reliable insurance remains one of the most urgent challenges. As she notes, even with groundbreaking innovation, patients still struggle with affordability, systemic barriers and an overwhelming amount of information that is not always credible or tailored to their specific diagnosis. The conversation also examines the evolving role of patient advocacy and the partnerships needed to drive meaningful change. Traxel emphasizes the importance of integrating lived experiences into policy, improving the credibility of patient-facing communication and strengthening early, ongoing collaboration between biopharma, policymakers and advocacy organizations. She also highlights two top priorities for U.S. cancer policy by 2030: reducing out-of-pocket costs and improving nationwide screening rates. For healthcare and life sciences professionals seeking deeper insight into how access, innovation and policy must intersect to improve patient outcomes, this is a must-listen episode.See omnystudio.com/listener for privacy information.

Last week, the Beacon hospital became the first hospital in Ireland or the UK and only the 5th in Europe, to treat a patient using Varian's new RapidArc Dynamic technology. It is an advancement in radiotherapy technology for cancer care that improves precision, reduces treatment time, and lowers radiation exposure to surrounding healthy tissue.To explain more about the technology Pat spoke to Dr Siobhra O'Sullivan, Consultant radiation oncologist in the Beacon hospital.

Today, we'll be tackling the future of prostate cancer care. We'll be reflecting on what prostate cancer care means in practice, how the way we think about the disease is shifting, and must continue to shift in the years ahead. Scientific advances have transformed treatment in recent years, yet the lived reality of prostate cancer still extends far beyond the clinic. The disease reshapes daily life, and may leave men and their families grappling with difficult choices about how best to manage it.  Dr. Güneş Taylor is joined by three key voices at the centre of this story, following the prostate cancer journey from diagnosis through to long-term management, and asking how patients and clinicians can work together to re-think what patient-centred care could mean in the years to come. This episode is brought to you in collaboration with Bayer, part of their Prostate Cancer Perspectives series.  PP-UN-ONC-GB-0168. November 2025 References Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263 (Prostate cancer is the second most common cancer in men and the fifth leading cause of cancer death worldwide) James D, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683–1722 (Each year, around 1.5 million men are diagnosed and nearly 400,000 lose their lives to the disease.1 And the numbers are rising. Diagnoses are projected to double from 1.4 million annually in 2020 to 2.9 million by 2040) Siegel RL, et al. Cancer statistics, 2022. Ca Cancer J Clin. 2022;72:7–33 (In the U.S., the proportion of men diagnosed with advanced-stage prostate cancer has doubled in recent years, due to increasing incidence of advanced-stage disease and changing guidelines regarding the prostate specific antigen screening test, implemented in the U.S. in 2012) Dodkins J, et al. Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population based evaluation. BMJ Oncology. 2025;4:e000643 (In England, nearly one in five men only receive a diagnosis once their cancer has spread) Calvo-Schimmel A, et al. Supportive care interventions and quality of life in advanced disease prostate cancer survivors: An integrative review of the literature. Can Oncol Nurs J. 2021;31(4):412-429 (Advanced prostate cancer is often associated with long-term challenges leading to greater levels of unmet needs in supportive care) Learn more about your ad choices. Visit podcastchoices.com/adchoices

Love the episode? Send us a text!In this powerful episode of Breast Cancer Conversations, host Laura Carfang, Ed.D. sits down with philanthropist Sheri Biller of the Sheri and Les Biller Family Foundation to explore the often overlooked—but absolutely essential—role of supportive cancer care.After losing her two closest friends to breast cancer over 35 years ago, Sheri made a promise: if she ever had the resources, she would dedicate her life to improving the emotional, psychological, and practical support available to everyone facing cancer. That promise became the Biller Family Foundation and later the national coalition Together for Supportive Cancer Care.This episode dives deep into:Why the words supportive care matter—and how they differ from palliative and hospice careHow siloed hospital systems leave millions without access to emotional and psychosocial supportWhy cancer is becoming an elitist disease—and how technology and policy can fix itCaregiver burnout and why Sheri believes we need a “Teach for America” for caregiversThe shocking lack of trust, education, and information in underserved and rural communitiesWhy supportive care should be a standard of care for all life-threatening illnessesIf you're a patient, caregiver, clinician, or advocate for equity in cancer care, this conversation is a must-listen.Topics We Cover✔️ Sheri's personal story and the loss that inspired her life's work ✔️ Early challenges in cancer language, communication, and stigma ✔️ Why patients “shut down” the moment they hear the word cancer ✔️ Supportive care vs palliative care—what's the difference? ✔️ Breaking barriers for rural, underserved, and Spanish-speaking communities ✔️ Why caregivers are the next major crisis in healthcare ✔️ The need for culturally competent engagement in faith communities ✔️ Financial toxicity and the real-world burdens families face ✔️ AI and the future of early diagnosis and survivorship support ✔️ How hospitals, pharma, policy, and nonprofits are finally working togetherWhy This MattersSupportive care is more than comfort—it's critical to surviving and living with cancer. From mental health to financial navigation to caregiver support, Sheri explains how integrating supportive care into every diagnosis could transform outcomes for millions.Resources: The Biller Family Foundation: https://billerfamilyfoundation.org/Donate Here and Give The Gift of HopeSupport the showLatest News: Become a Breast Cancer Conversations+ Member! Sign Up Now. Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources! Enjoying our content? Please consider supporting our work.

In this special session from the upcoming Prostate Summit 2.0, Dr. Eric Zielinski sits down with Dr. Geo for a rare, vulnerable and informative conversation about the why behind his life's work in prostate cancer care.Key PointsThe emotional and spiritual side of working with thousands of menWhy your why matters more than the diet, protocol, or treatment choiceThe 3 buckets of prostate cancer and why care must be personalizedHis 4 pillars of healing: lifestyle, nutrition, fitness, and stress masteryHow fasting, cruciferous veggies, mushrooms, herbs, and targeted nutraceuticals help build resilienceWhy exercise is non-negotiable, and how sitting all day harms prostate and metabolic healthThis episode blends heart, science, and practical strategy to help men live longer and better with prostate cancer.Chapters00:00 – Intro02:00 – The “why” behind Dr. Geo's work07:00 – A powerful patient story & legacy12:00 – The 3 buckets of prostate cancer18:00 – Food, fasting & “It Days”23:00 – Exercise, sitting & movement32:00 – Mushrooms, herbs & targeted nutraceuticalsFrom the upcoming Prostate Summit 2.0

Exocrine pancreatic insufficiency (EPI) affects many patients with pancreatic cancer, yet it is often overlooked in this patient populations, which leads to malnutrition. In this episode, we are joined by Dr. Shelby Yaceczko, DCN, RDN, CNSC. Yacescko is a supporting author on a recently published White Paper on the topic, and she explains what EPI is, how to screen for and treat the condition, and the essential role of dietitians in an interdisciplinary care team managing these patients.  In this episode, we discuss: How overlapping GI symptoms, lack of standardized screening tools, and limited guidelines contribute to missed diagnoses and delayed treatment What inspired the development of the White Paper How to bring EPI management into everyday practice The ready-to-use checklists, screening forms, and EHR templates within the White Paper designed to standardize treatment Hosted by Kristin Houts Click here for the shownotes. The content, products and/or services referred to in this podcast are intended for Health Care Professionals only and are not, and are not intended to be, medical advice, which should be tailored to your individual circumstances. The content is for your information only, and we advise that you exercise your own judgement before deciding to use the information provided. Professional medical advice should be obtained before taking action. The reference to particular products and/or services in this episode does not constitute any form of endorsement. Please see here for terms and conditions.

Cancer care isn't what it used to be—and that's exactly why Dr. Douglas Flora just wrote a book about it. Are you ready to understand how AI is transforming oncology? In this episode of AI and Healthcare, host Dr. Sanjay Juneja and co-hosts Dr. Douglas Flora and Dr. Deborah Pat are joined by special guest Dr. Chadi Nabhan—author, educator, and passionate advocate for cancer education—to discuss Doug's newly released book on AI in cancer care, currently #1 in oncology on Amazon. Doug wrote it because he feels "desperate" to share how dramatically cancer treatment is changing. The physicians reflect on how far oncology has come from mixing chemotherapy by hand to AI-powered precision medicine. Whether you're a healthcare professional, cancer survivor, or curious about AI in medicine, this conversation offers an honest look at where oncology is headed. New episodes every two weeks.

A doctor’s choice to walk beside patients through their hardest moments comes from a calling to serve with both skill and heart. Dr. Angela Coscio’s love for people led her from lab research to breast cancer specialization, where she witnesses courage every day. At St. Luke’s, she finds purpose in connecting deeply with patients, guiding them through treatment with compassion and individualized care. Her story reflects teamwork, devotion, and the belief that every medical decision should be a true partnership. Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered Did Dr. Coscio always want to be a doctor? What path did Dr. Coscio take to become a physician? What is the role of an oncologist? How does Dr. Coscio deliver a cancer diagnosis? Why did Dr. Coscio choose oncology as her specialty? What happens at a tumor board? What does being in a comprehensive cancer center like St. Luke’s mean for patients? Are cancer treatment options personalized? How does Dr. Coscio address questions about treatment options, such as chemotherapy vs. hormone therapy? How important is the caregiver's role in cancer treatment and recovery? Does Dr. Coscio encourage second opinions? What advice does Dr. Coscio have for young women facing breast cancer? How does Dr. Coscio support patients in communicating and preparing for doctor appointments? Timestamped Overview 05:06 Interpreter Self-Doubt in Spanish 07:37 Collaborative Patient Care Discussion 10:24 St. Luke's: Team & Care 16:23 Connections in Cancer Care 19:39 Chemotherapy Decision Based on Science 20:45 Engineering Mindset Meets Oncology 25:08 Key Questions for Cancer AppointmentsSee omnystudio.com/listener for privacy information.

Upon receiving a cancer diagnosis, the first priority is to build a clinical treatment plan. But there is another equally...[…]

Upon receiving a cancer diagnosis, the first priority is to build a clinical treatment plan. But there is another equally...

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sat down with Mark Socinski, MD, a medical oncologist and the executive medical director of the AdventHealth Cancer Institute in Orlando, Florida. Drs Camidge and Socinski discussed the highlights of Dr Socinski's career trajectory, as well as the personal influences that helped him arrive where he is today. Socinski describes himself as a clinician and clinical investigator with 35 years of focus on lung cancer. His role as executive director of the AdventHealth Cancer Institute involves maintaining an active clinic 1 day a week and dedicating the rest of his time to administrative duties, including recruitment and building infrastructure at the institution. In the interview, Dr Socinski explained that he was influenced to enter a career in medicine because of role of the family practitioner he knew growing up. He went on to receive undergraduate and medical degrees from the University of Vermont in Burlington. After training at Dana-Farber Cancer Institute in Boston, Massachusetts, he began his career in private general oncology practice in Vermont before seeking a more academic, subspecialty environment. He joined the University of North Carolina to concentrate on lung cancer, where he pioneered dose-escalation trials using conformal radiotherapy. Dr Socinski then described his move to the University of Pittsburgh Medical Center in Pennsylvania. There, he became the chair of the lung pathway, which limits treatment options to a single, expert-agreed standard of care based on efficacy, toxicity, and cost, thus reducing treatment heterogeneity and controlling costs. Thereafter, Dr Socinski moved to AdventHealth, attracted by the institution's goal to achieve National Cancer Institute designation and build a major cancer program. Dr Socinski shared that he finds it gratifying to care for patients and lead the development of the institute.

In this deeply inspiring episode of Keeping Abreast, Dr. Jenn Simmons welcomes Dr. Pete Sulack—chiropractor, functional medicine practitioner, and founder of Unhealthy Anonymous—for a powerful conversation about defying the odds after a terminal cancer diagnosis.Dr. Sulack shares how he turned a death sentence into a journey of hope, healing, and renewal. Through faith, nutrition, and lifestyle transformation, he reclaimed his health and now guides others to do the same. Together, he and Dr. Jenn challenge conventional cancer paradigms, exploring how mindset, personalized nutrition, and spiritual alignment can unlock the body's innate capacity to heal.This episode invites listeners to rethink what's possible in cancer recovery and beyond. It's a story of courage, resilience, and faith in both science and spirit—reminding us that health is not something we outsource but something we build from within.In This Episode, You Will Learn:How Dr. Sulack overcame a terminal brain cancer diagnosisWhy functional medicine focuses on healing the whole person, not just treating diseaseThe crucial role of personalized nutrition in recoveryHow food sensitivities and gut health shape overall wellnessWhy conventional medicine often overlooks the importance of dietThe link between faith, mindset, and the body's innate ability to healHow to take proactive responsibility for your healthWhy empowerment and education can change the cancer care paradigm

Never miss another webinar! Signup here: https://imahealth.org/weekly-webinars Learn more: https://imahealth.org/beyond-breakthroughFor more than 50 years, cancer research has chased a single dream: the breakthrough cure that would finally end the disease. But what if that search has taken us down the wrong path?In this week's episode, IMA Senior Fellow Dr. Ryan Cole and IMA Co-Founder Dr. Paul Marik sat down with filmmaker Justin Smith, director of the documentary Beyond Breakthrough, to discuss the growing movement of scientists, doctors, and patients who are redefining what healing really means.Justin shared how creating the film challenged his own assumptions about cancer and how what he discovered may reshape the way you see it too.Together, they explored:How the “breakthrough mindset” has shaped modern cancer researchThe rise of integrative, metabolic, and bioelectric therapiesWhy collaboration across disciplines may hold the key to progressWhat it means to change not just how we treat cancer, but how we understand itThis powerful conversation invited viewers to question long-held beliefs, consider new possibilities, and see cancer care through a more hopeful, holistic lens.• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

Jim Foote, CEO and Founder of First Ascent Biomedical a pioneer in functional precision medicine (FPM) that aims to eliminate guesswork from cancer treatment. After losing his son to cancer, Jim left a career in cybersecurity to build a data-driven platform that combines AI, robotics and real-time tumour testing to help doctors choose the right therapy for each patient. In this episode, we explore how FPM differs from traditional genomics-only testing, why tumours can respond differently even with the same patient and how AI can support rather than replace clinicians in treatment decisions. Jim also shares the economic impact of ineffective therapies, the challenges of scaling regulatory innovation in oncology, and why the future of cancer care depends on personalisation at the  cellular level.Timestamps:[00:00:45] What Is Functional Precision Medicine?[00:02:00] Jim's Personal Journey from Tech to Healthcare[00:05:50] Overcoming Regulatory and Systemic Gatekeepers[00:08:13] From Reactive Care to Personalised Treatment[00:09:08] What Lab Findings Reveal about Cancer Cells[00:10:30] Why Genomics Alone Isn't Enough[00:12:03] AI as Decision Support Not a Decision Maker[00:15:55] Cancer in Younger Populations and Misconceptions[00:20:25] Reducing Cost and Waste in Cancer Treatment[00:26:34] What Success Really Means to Jim FooteConnect with Jim - https://www.linkedin.com/in/jim-foote/ Learn more about First Ascent Biomedical - https://www.linkedin.com/company/firstascentbio/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwalSubscribe to the Podcast

In today's episode, we had the pleasure of speaking with Neal Shore, MD, FACS, about the use of androgen deprivation therapy (ADT) in prostate cancer management. Dr Shore is medical director of the Carolina Urologic Research Center in Myrtle Beach, South Carolina. In our exclusive interview, Dr Shore discussed guidelines for incorporating ADT into prostate cancer clinical practice, toxicities and quality-of-life complications associated with this class of agents that health care providers should be aware of and try to mitigate, and the importance of shared decision-making between members of the multidisciplinary team, as well as patients.

On this edition of The Mark White Show, we're shining a light on the often-overlooked heroes in prostate cancer care, the caregivers. A new national survey reveals that 85% of caregivers attend medical appointments with their loved one and are four times more likely to notice treatment side effects than the patients themselves. Joining me are Dr. Daniel George, Medical Oncologist and Professor at Duke University School of Medicine, and Gina Carithers, President of the Prostate Cancer Foundation. Together, we discuss what this survey uncovers about the day-to-day realities of caregiving, how families can better navigate this journey, and the vital importance of supporting those who give so much of themselves in the process.

In this episode, host Shikha Jain, MD, speaks with Maureen McBeth, PT, MPT, CLT-LANA, about understanding individualized patient experiences with lymphedema, the value of exercise oncology and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About McBeth 0:23 • The interview 0:52 • How did you end up in the lymphedema and cancer rehab space? 1:31 • Why is lymphedema such a big topic, especially in the breast cancer space? 3:20 • Jain and McBeth on the complexities of individual lymphedema cases, including studies on lymphatic imaging. 5:25 • Do you feel like there have been advancements in the lymphedema space that can improve our understanding of it? 9:43 • Have stigmas around lymphedema evolved over the years? 12:31 • McBeth on the educational materials available to physicians surrounding cancer-related lymphedema and prospective surveillance. 15:15 • Tell us about ImpediMed and its purpose. 17:06 • How do you incorporate these technologies into the current dialogue about more holistic care? 21:27 • Jain and McBeth on exercise oncology and its impact on overall survival. 24:22 • In ten years, what would you envision as the future of lymphedema and exercise oncology? 29:01 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 32:31 • How to contact McBeth 33:33 • Thanks for listening 34:20 Maureen McBeth, PT, MPT, CLT-LANA, is a licensed physical therapist and certified lymphedema therapist with over 25 years of experience in oncology rehabilitation, clinical education, and patient advocacy. She currently serves as senior medical affairs liaison at ImpediMed. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. McBeth can be reached via email mmcbeth@impedimed.com. Learn more about ImpediMed at https://www.impedimed.com/, or follow them on LinkedIn or Instagram @impedimedhealth. References • Pasket ED, et al. J Clin Oncol. 2012;doi:10.1200/JCO.2012.41.8574 • Schmitz KH, et al. J Natl Cancer Inst Monogr. 2025;doi:10.1093/jncimonographs/lgaf007. • Stout NL, et al. Cancer. 2012;doi:10.1002/cncr.27476. Disclosures: Jain and McBeth report no relevant financial disclosures.

In this episode, Ziad Hanhan, MD, hosted a discussion about lung cancer diagnosis, surgical management, and evolving treatment paradigms. Dr Hanhan is a thoracic surgeon at Hackensack Meridian Health, chairman of Surgery at Bayshore Medical Center in Holmdel, New Jersey, and chief of Thoracic Surgery at Riverview Medical Center in Red Bank, New Jersey. He was joined by: Thomas Bauer, MD, the chair of surgery at Jersey Shore University Medical Center in Neptune Township, New Jersey, and Hackensack Meridian Health School of Medicine Rachel NeMoyer, MD, a thoracic surgeon at Hackensack Meridian Health Drs Hanhan, Bauer, and NeMoyer discussed current standards and future directions in thoracic oncology, emphasizing multidisciplinary collaboration and technological innovation. The conversation opened with an overview of lung cancer epidemiology, and the experts noted that this disease remains the leading cause of cancer-related mortality in both men and women. They explained that approximately 90% of lung cancer cases are attributable to tobacco use, making cessation a key preventive measure. They also emphasized that early detection through low-dose CT screening improves outcomes when the disease is identified at an early stage. However, despite these advances, they stated that most lung cancer cases in the United States continue to be diagnosed at stage III or IV, underscoring the need for improved screening adherence. They expanded on current lung cancer screening guidelines and noted that lung cancer often presents with nonspecific symptoms, such as chronic cough or hemoptysis, and that many cases are discovered incidentally on imaging. The surgeons also discussed diagnostic strategies for pulmonary nodules and emphasized a patient-tailored approach that balances diagnostic yield with procedural risk. They also acknowledged that emerging modalities, such as liquid biopsy and breath-based DNA detection, are promising but still investigational. They underscored that frailty assessment remains integral to surgical candidacy determination, with both clinical evaluation and pulmonary function testing guiding decision-making. The team also highlighted the role of multidisciplinary tumor boards in integrating surgical, medical, and radiation oncology perspectives. For early-stage disease, surgery remains the standard, whereas patients with stage III disease typically receive neoadjuvant therapy incorporating immuno-oncology agents. The group also discussed expanding surgical indications in select stage IV cases, reflecting improved survival associated with immunotherapy.

In cancer care, ethical challenges rarely come with easy answers.When should treatment stop? How do teams manage moral distress? And what happens when AI begins to shape clinical decisions?In this episode, Dr. Nico Nortjé, Executive Director for the Center for Clinical Ethics in Cancer Care at MD Anderson Cancer Center, joins host Ginger to explore how oncology professionals navigate those moments when medical facts and human emotions collide.Dr. Nortjé shares what he's learned from leading ethics consultations, guiding care teams through end-of-life discussions, moral distress, and the new ethical questions raised by technology.You'll learn:How to recognize and address moral distress before it leads to burnoutHow ethics consults can turn uncertainty into team alignmentHow to approach treatment-limiting conversations with empathyWhat to consider when AI starts influencing care decisionsListen for a grounded, thoughtful look at what ethics really means in oncology today.

Cancer care should be close to home. It's not just convenient, it's necessary for good patient outcomes. We take a closer look at the growing options in the Northland for patients and their families.

Love the episode? Send us a text!Today's episode is going to challenge how you think about treatment. What if cancer care wasn't one-size-fits-all? What if every decision — from the drugs you take to the supplements you choose — was tailored to your own biology?My guest, Dr. John Oertle, Chief Medical Director at Envita Medical Centers, has spent over 25 years pioneering a truly personalized, integrative approach that merges precision oncology, functional medicine, and technology.We'll explore why some people respond to treatment while others don't, what circulating tumor DNA can tell us about recurrence, and how understanding environmental toxins and genetics can literally change your odds.

This episode of Integrative Cancer Solution features an in-depth conversation with Dr. Christina M. Dieli-Conwright, Associate Professor at Dana Farber Harvard Medical School, who specializes in exercise oncology. Christina begins by sharing her unique career path, transitioning from veterinary medicine to clinical exercise physiology, and ultimately focusing her research on the intersection of exercise and cancer care. Her journey highlights the importance of pursuing one's passions and the impact of interdisciplinary expertise in advancing the field of exercise medicine for cancer patients. A significant portion of the episode centers on the physiological benefits of exercise for those living with cancer. Christina notes that exercise plays a crucial role in improving diverse body systems—from cognitive to immune function—and directly enhances quality of life, helps manage treatment side effects, and may even extend survival. She discusses her involvement in the Department of Nutrition, where she helps craft individualized exercise and nutrition strategies tailored to the unique needs of cancer survivors. The discussion highlights how both aerobic and resistance training are vital components of an optimized exercise program for cancer patients. Christina explains the current guidelines, advocating for at least 150 minutes per week of moderate-to-vigorous aerobic activity, complemented by strength training. She stresses, however, that these recommendations should be adapted to each patient's medical history, treatment stage, and overall health status, with frequent assessments to monitor progress and make necessary adjustments. Christina justifies these approaches with evidence from ongoing clinical trials and epidemiological studies, specifically citing strong data supporting exercise benefits for breast and colon cancer survivors. She also addresses the importance of combining exercise with other interventions, such as fasting, to maximize health outcomes and better manage symptoms like fatigue or hormonal imbalance. Despite the positive trends, Christina is candid about research gaps and the need for more precise, personalized guidelines, particularly for less-studied cancers or unique survivor populations. The episode concludes by empowering cancer survivors to seek out reliable resources for exercise guidance—such as the American Cancer Society and the American College of Sports Medicine—and to maintain motivation through personal support networks and physician recommendations. Christina leaves listeners with the message that consistent, individualized exercise is a transformative tool for surviving and thriving beyond cancer, reinforcing the broader theme that exercise is not only safe but essential for improving both the quality and longevity of life for those affected by cancer.Dr. Christina M. Dieli-Conwright explains how individualized exercise prescriptions can improve cognitive, immune, and overall health outcomes for cancer patients.The episode highlights the importance of both aerobic and resistance training, recommending at least 150 minutes per week of moderate-to-vigorous activity for survivors.Combining exercise with strategies like fasting can help manage fatigue and improve glycemic control during cancer therapy.Clinical evidence shows that exercise during and after cancer treatment is linked to better quality of life and potentially higher survival rates, especially for breast and colon cancers.Reliable resources like the American Cancer Society and American College of Sports Medicine provide support for cancer survivors seeking to tailor exercise to their unique needs.____________________________________If you're ready to expand your mind, elevate your health, and awaken your full potential, subscribe now and join the revolution in conscious living with The Dr. K Show!____________________________________CONNECT WITH DR. K: Website: TheKarlfeldtCenter.comWebsite: TrueHealthShow.comInstagram: https://www.instagram.com/thekarlfeldtcenter/The Science and Spirit of Transformation: A Holistic Guide to Elevating Health, Consciousness, and PurposeURL: https://store.thekarlfeldtcenter.com/products/the-science-and-spirit-of-transformation-Price: $24.99-100% Off Discount Code: DRKSHOWPODCAST_____________________________________The Dr. K Show & Integrative Cancer Solutions were created to instill hope and empowerment. Other people have been where you are right now and have already done the research for you. Listen to their stories and journeys and apply what they learned to achieve similar outcomes as they have, cancer remission and an even more fullness of life than before the diagnosis. Guests will discuss what therapies, supplements, and practitioners they relied on to beat cancer. Once diagnosed, time is of the essence. This podcast will dramatically reduce your learning curve as you search for your own solution to cancer. To learn more about the cutting-edge integrative cancer therapies Dr. Karlfeldt offer at his center, please visit www.TheKarlfeldtCenter.com____________________________________If you're ready to expand your mind, elevate your health, and awaken your full potential, subscribe now and join the revolution in conscious living with The Dr. K Show!____________________________________CONNECT WITH DR. K: Website: TheKarlfeldtCenter.comWebsite: TrueHealthShow.comInstagram: https://www.instagram.com/thekarlfeldtcenter/The Science and Spirit of Transformation: A Holistic Guide to Elevating Health, Consciousness, and PurposeURL: https://store.thekarlfeldtcenter.com/products/the-science-and-spirit-of-transformation-Price: $24.99-100% Off Discount Code: DRKSHOWPODCAST_____________________________________The Dr. K Show & Integrative Cancer Solutions were created to instill hope and empowerment. Other people have been where you are right now and have already done the research for you. Listen to their stories and journeys and apply what they learned to achieve similar outcomes as they have, cancer remission and an even more fullness of life than before the diagnosis. Guests will discuss what therapies, supplements, and practitioners they relied on to beat cancer. Once diagnosed, time is of the essence. This podcast will dramatically reduce your learning curve as you search for your own solution to cancer. To learn more about the cutting-edge integrative cancer therapies Dr. Karlfeldt offer at his center, please visit www.TheKarlfeldtCenter.com

Drs. Ghazal Zandieh, Yash Singh, Thomas DeSilvio, and Brennan Flannery speak with Dr. Joseph Ippolito about how metabolic imaging is transforming cancer diagnosis and treatment through advanced PET and MRI techniques. Together they explore how personalized medicine and sex-specific metabolic differences are reshaping the way radiologists understand and treat glioblastoma. Radiology: Imaging Cancer Journal

This episode is sponsored by IDEXX This podcast episode, hosted by Adam Christman, DVM, MBA, features oncologists Dana Connell, DVM, MPH, DACVIM (Oncology) and Zachary L. Neumann, DVM, MS, DACVIM (Oncology), discussing the significance of early cancer detection in dogs. The conversation focuses on the IDEXX Cancer Dx testing. The doctors explain how the test, which can be included in routine wellness exams, provides rapid results, enabling veterinarians to make timely diagnoses and improve treatment outcomes. They also touch on the importance of the veterinary team in communicating sensitive news to pet owners and the future potential of the test to screen for other types of cancer.

Behind every oncology referral is a patient—and a family—waiting, hoping, and depending on the system to move fast. In this episode, host Dr. Elizabeth Woodcock, Executive Director of the Patient Access Collaborative, is joined by three oncology access leaders: Kristen Thatcher of The James at Ohio State University, Jennifer Kennedy-Stovall of Duke Cancer Institute, and Kate Healy-Levine of Memorial Sloan Kettering Cancer Center. Together, they explore how leading cancer programs are redefining timely access—balancing urgency with empathy, operational efficiency with equity, and data with culture.Tune in to hear how these systems are tackling workforce constraints, leveraging APPs, and redesigning scheduling models to ensure that every patient receives the right care, at the right time.Topics include culture and urgency in access, diagnostic and APP models, template standardization, financial navigation, and equity in oncology care.

Live this week from the ACCC's 42nd National Oncology Conference (NOC), CANCER BUZZ speaks with ACCC Executive Director Meagan O'Neill, MS, who previews the week.  Guest:  Meagan O'Neill, MS Executive Director, Association of Cancer Care Centers   Resources:  ACCC 42nd National Oncology Conference Agenda